Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 17 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

38%

3 of 8 completed with results

Key Signals

3 with results100% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (5)
Early P 1 (1)
P 1 (2)
P 2 (7)

Trial Status

Completed8
Active Not Recruiting4
Unknown3
Withdrawn1
Suspended1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT03077841Phase 2Suspended

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer

NCT04290897Phase 2Completed

Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors

NCT02129686Not ApplicableCompleted

A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients

NCT04294225Phase 2Completed

Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer

NCT02474641Not ApplicableActive Not RecruitingPrimary

Hypofractionation With Simultaneous Integrated Boost vs. Standard Fractionation in Early Breast Cancer

NCT04081389Phase 1Completed

Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer

NCT03025139Not ApplicableUnknown

Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness)

NCT04560439Not ApplicableWithdrawn

Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer Survivors

NCT02603679Phase 2Active Not RecruitingPrimary

Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases

NCT02568839Phase 2Active Not RecruitingPrimary

Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer

NCT02481128Not ApplicableCompletedPrimary

Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast Cancer

NCT02592083Phase 2Active Not RecruitingPrimary

Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors

NCT02441946Phase 2Completed

A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer

NCT02947425UnknownPrimary

TARGeted Intraoperative radioTherapy (TARGIT) Registry Database

NCT02806817Early Phase 1Completed

ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism

NCT02511301Phase 1UnknownPrimary

Circadian Thermal Sensing to Detect Breast Disease

NCT02310984CompletedPrimary

PICTURE Breast XS: Patient Information Combined for Local Therapy oUtcome Assessment in bREast Cancer - Cross-sectional

Showing all 17 trials

Research Network

Activity Timeline